Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ZYXI - Zynex Inc


IEX Last Trade
7.88
-0.100   -1.269%

Share volume: 199,837
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$7.98
-0.10
-1.25%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
64%
Profitability 62%
Dept financing 48%
Liquidity 58%
Performance 73%
Company vs Stock growth
vs
Performance
5 Days
-4.03%
1 Month
-4.38%
3 Months
-20.77%
6 Months
-41.73%
1 Year
1.42%
2 Year
-10.38%
Key data
Stock price
$7.88
P/E Ratio 
41.33
DAY RANGE
N/A - N/A
EPS 
$0.18
52 WEEK RANGE
$6.88 - $13.77
52 WEEK CHANGE
$0.04
MARKET CAP 
249.496 M
YIELD 
N/A
SHARES OUTSTANDING 
31.743 M
DIVIDEND
$0.10
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
BETA 
0.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$103,708
AVERAGE 30 VOLUME 
$120,551
Company detail
CEO:
Region: US
Website: zynexmed.com
Employees: 891
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.

Recent news